Sir,
Tuberculous meningitis is a common cause of chronic meningitis in India. However, pure tuberculous encephalitis (TbE) is rare and overshadowed by meningitis or mass lesions such as tuberculomas. A 17-year-old girl presented with aphemia. Examination revealed a right upper motor neuron facial palsy with effortful speech, articulatory groping and buccofacial apraxia, with preserved verbal comprehension, reading, and writing (Aphemia). Oropharyngeal movements were normal. Abdominal lymph node biopsy 8 months earlier had shown reactive lymphadenopathy. Six months earlier, she had developed right-sided hearing loss and right lower motor neuron 7 th nerve palsy. Magnetic resonance imaging (MRI) brain showed a left medial occipital lobe lesion along with a ring-enhancing lesion in the right petrous apex [ Figure 1 ]. Cerebrospinal fluid (CSF) examination was normal, and she improved with intermittent steroid therapy (prednisolone 45 mg/day). As she refused a biopsy, prednisolone was continued with a provisional diagnosis of sarcoidosis. Mantoux test, angiotensin converting enzyme levels, Brucella IgM and IgG and a bacterial and fungal CSF polymerase chain reaction (PCR) panel were negative. One week earlier, she had come with transient speech arrest resolving after 24 h. Both times, MRI brain with contrast showed no new changes. Electroencephalogram (EEG) showed severe left hemispheric slowing, and she was administered intravenous levetiracetam and sodium valproate for presumed epileptic aphasia. However, continuous EEG monitoring for 4 days showed only left hemispheric slowing without any epileptiform discharges. 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) showed FDG avid adenoid tissue, as well as small mediastinal, para aortic, and abdominal lymph nodes along with multiple avid splenic lesions. There was a lytic lesion in the right petrous apex as well as diffuse FDG uptake in the left operculum and anterior cingulate gyrus [ Figure 2 ].
Bone marrow biopsy and flow cytometry were normal. Adenoid biopsy showed scanty acid-fast bacilli (AFB), but GeneXpert and tuberculosis (Tb) PCR on the tissue were negative. Immunostaining of the specimen for lymphoma was negative. She was started on antituberculous treatment (ATT) (RHZE) with Dexa 12 mg/day. A repeat CSF examination showed 48 cells with 100% lymphocytes and normal protein. Two months later, she presented in a stuporous state. At month 9, a new MRI was suggestive of optochiasmatic arachnoiditis with endarteritis and mesodiencephalic infarcts. Steroids were escalated, and they left elsewhere for evaluation.
There, a repeat PET-CT showed a metabolically active irregular enhancing area along the basal cisterns extending along the middle cerebral artery branches bilaterally with a new lytic lesion in the right sacral ala and splenic FDG avid lesions. The sacral lytic lesion was biopsied. This time, AFB smear and GeneExpert for Mycobacterium tuberculosis were positive. She was started on 5-drug ATT (RHEZ + moxifloxacin) with steroids and came back to us for follow-up. An MRI at 18 months of treatment showed decreased enhancement around the suprasellar cistern. PET-CT showed diffuse left hemispheric hypometabolism, but her splenic lesion remained FDG avid at 18 months. Repeated MRIs at 9 and 18 months showed no new lesions and the opercular area remained normal. She continued 5 drugs ATT for 24 months and finally discontinued it herself. She remains ambulant with persistent aphemia. At 30 months' follow-up, a repeat PET-CT showed persistent left cerebral hemispheric hypometabolism. MRI brain was normal.
Tuberculous Encephalitis with Aphemia Detected Only by 18 F-Fluorodeoxyglucose-Positron Emission Tomography
As the bacillary load is low in TbE, the CSF PCR is negative, and diagnosis can be elusive. Initial CT or MRI scans are normal in 35% of patients with TbE, although eventually tuberculomas, miliary nodules, cerebritis, abscesses, ventriculitis, or arachnoiditis are found. [1, 2] 18 F-FDG PET/CT is very useful in the diagnosis of central nervous system infections increased tissue uptake of 18 F-FDG is attributed to increased cell density, overexpression of GLUT-1 and GLUT-3 transporter isotypes and by increased hexokinase activity. FDG PET in tuberculomas may show a characteristic ring-like or "doughnut" pattern, with low uptake within the abscess cavity and peripheral increased uptake. [3, 4] 18 F-FDG PET/CT findings usually correlate with MRI abnormalities.
In encephalitis, FDG PET shows hypermetabolism in the active stage and hypometabolism in the chronic stage. [5] In autoimmune encephalitis, such as N-methyl D-aspartate receptors encephalitis, a mixed picture of hyper-and hypo-metabolism is encountered. [6] Our patient also demonstrated serial evolution of FDG-PET changes from hypermetabolism to hypometabolism in the opercular region after the initiation of ATT.
In our patient, the serial evolution of PET-CT changes along with AFB positivity with biopsy from 2 disparate sites and suggested an inflammatory lesion, consistent with TbE [ Table 1 ]. Our patient exhibited two unusual characteristics. 18 F-FDG PET/CT showed a focal encephalitis in the left frontal opercular area with consistently normal MRI findings in this region. Moreover, her FDG PET findings evolved with time consistent with the resolution of her TbE. Second, she presented with an unusual case of aphemia secondary to the TbE.
Aphemia (Cortical anarthria) lies in a continuum of articulatory and language disorders [ Supplementary Figure 1 ]. It is often called an apraxia of speech. The lesion implicated lies in the left precentral gyrus near the face area in the frontal lobe.
In conclusion, 18 F-FDG PET/CT may detect areas affected by TbE, even if the MRI is normal. 18 F-FDG PET-CT is also useful in the assessment of treatment response to Tb as a reduction in hypermetabolism often precedes radiological improvement.
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Lacosamide Associated Complete Heart Block in Elderly
Sir, A case of a 71-year-old female, suffering from hypertension (controlled on metoprolol 25 mg/day and telmisartan 40 mg/day) for the last 4 years, presented to us with a history of three episodes of focal seizures before 5 months. Her magnetic resonance imaging brain at that time revealed small-vessel ischemic changes, and electroencephalogram was normal. Advised antiepileptic with levetiracetam 500 mg twice daily, and later on, the dose increased to 500 mg thrice daily in view of uncontrolled seizures. One month later, she complained another episode of seizure, so she was prescribed second antiepileptic drug, lacosamide (LCM) 100 mg twice daily, the dose of which increased to 100 mg thrice daily in view of recurrence of seizures. After 5 days of escalation of LCM dose, she presented with a complaint of loose, watery stools for 2 days and altered sensorium for 1 day. On admission, she had blood pressure of 90/60 mmHg with pulse rate of 36/min and electrocardiogram (ECG) indicating complete heart block (CHB) [ Figure 1 ]. Hence, a temporary pace maker was implanted. On investigating, she found to have severe metabolic acidosis with raised lactate level. Her serum creatinine level was raised (3.35 mg/dL), and electrolytes were within normal limit. She had raised liver enzymes -serum glutamic pyruvic transaminase (SGPT) 832 IU/L, SGPT 1364 IU/L with normal bilirubin level, normal partial thromboplastin, and activated partial thromboplastin time value. All viral markers for hepatitis were negative. A diagnosis of multifactorial metabolic encephalopathy due to multiorgan failure due to hypotension (gastroenteritis and CHB) was considered. Metoprolol was discontinued due to CHB and LCM was also stopped in view of its cardiac side effect profile and levetiracetam was continued. She was treated with intravenous fluids and antibiotics. Two days later, CHB reverted to sinus rhythm and the temporary pacemaker was removed. Over the period of hospitalization, her hepatic and renal functions normalized.
LCM is a newer antiepileptic drug marketed since 2008. Its mechanism of action is by inactivation of voltage-gated sodium channels and is indicated as an "add-on" drug for partial onset seizures as well as for neuropathic pain modulation. It is reported to have good safety profile and only minimal side effects including nausea, headaches, dizziness, diplopia, and confusion. [1, 2] Cardiac side effects are infrequent, but may occur at therapeutic doses or at toxic level. These include mainly cardiac conduction abnormalities including ST-wave and T-wave changes and PR and QRS interval prolongation on ECG, [1] and rarely, it can lead to second-and third-degree atrioventricular (AV) block that is reversible after stopping LCM. [2, 3] Second-and third-degree block has rarely been reported at doses higher than 400 mg, with underlying renal disease or concomitant AV blocking drugs and preexisting AV block. [4] [5] [6] [7] In our case, we opined that there were mainly three reasons for CHB: first, older age, second, she was on drug that has negative dromotropic effect on AV conduction-metoprolol (although in low dose of 25 mg/day), and third, she developed impaired renal function due to new-onset diarrheal illness, leading to decreased LCM clearance. A dose-dependent accumulation of LCM leading to prolongation of PR interval is a rarely described adverse effect in preclinical and postmarketing studies. [8] A cause-effect relationship could definitely be established in our patient by the occurrence of CHB after dose escalation of LCM as well as its reversal with holding of LCM.
